Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to assess dietary protein requirements in clinically stable maintenance hemodialysis (MHD) patients. It is hypothesized that the average dietary protein intake (DP...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT07224763 · ESRD (End-Stage Renal Disease), Kidney Transplantation, and more
NCT07033260 · Intradialytic Hypotension, End-Stage Renal Disease Requiring Haemodialysis, and more
NCT06227468 · Healthy, Respiratory Disease, and more
Harbor-UCLA Medical Center
Torrance, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions